Vir Biotechnology names Brent Sabatini interim principal financial officer as CFO exitsPUBT·Jul 24 at 07:30 AMVIR+3.01%
Vir Biotechnology Announces Chief Financial Officer Transition | VIR Stock NewsStockTitan·Jul 23 at 11:30 PMVIR+3.01%
Vir Biotechnology schedules conference call on second-quarter 2026 resultsPUBT·Jul 22 at 03:07 PMVIR+3.01%
Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis BPR Newswire·Jul 2 at 07:00 PM02137-3.13%VIR+3.01%
Brii Biosciences says arbitration with Vir clouds future of elebsiran programPUBT·Jul 2 at 05:56 PM02137-3.13%VIR+3.01%
Morgan Stanley Raises Vir Biotechnology (NASDAQ:VIR) Price Target to $27.00Market Beat·Jun 11 at 07:47 AMVIR+3.01%
Vir Biotechnology, Inc. Stock 12‑Month Price Target Raised to $21.56, Implies 161% UpsideTradingView·Jun 11 at 02:20 AMVIR+3.01%
Assessing Vir Biotechnology (VIR) Valuation After Hepatitis Delta Data Update And Astellas Oncology PartnershipSimplywall·May 24 at 07:25 PMVIR+3.01%ALPMY+3.37%
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rallynasdaq·May 23 at 05:45 PMVIR+3.01%BBH-0.30%
